Atyr Pharma Stock Price Prediction

Intrinsic Valuation Low Real High 0.07 1.42 6.23 Details

Naive Forecast Low Next High 0.03 1.34 6.14 Details

Bollinger Band Projection (param) Lower Middle Band Upper 1.58 1.85 2.12 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as ATyr Pharma. Your research has to be compared to or analyzed against ATyr Pharma's peers to derive any actionable benefits. When done correctly, ATyr Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in aTyr Pharma.

ATyr Pharma After-Hype Price Prediction Density Analysis

ATyr Pharma Estimiated After-Hype Price Volatility

ATyr Pharma Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.20	4.81	0.00	0.03	0 Events / Month	5 Events / Month	Uncertain

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
1.59	1.59	0.00	0.00   Notes

ATyr Pharma Hype Timeline

aTyr Pharma is now traded for 1.59. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. ATyr is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.2%. %. The volatility of related hype on ATyr Pharma is about 3607.5%, with the expected price after the next announcement by competition of 1.56. About 62.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. aTyr Pharma recorded a loss per share of 0.94. The entity last dividend was issued on the 1st of July 2019. The firm had 1:14 split on the 1st of July 2019. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out ATyr Pharma Basic Forecasting Models to cross-verify your projections. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.

ATyr Pharma Related Hype Analysis

ATyr Pharma Additional Predictive Modules

Most predictive techniques to examine ATyr price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ATyr using various technical indicators. When you analyze ATyr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The number of cover stories for ATyr Pharma depends on current market conditions and ATyr Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ATyr Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ATyr Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

ATyr Pharma's future price predictability will typically decrease when ATyr Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of aTyr Pharma often depends not only on the future outlook of the potential ATyr Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma's indicators that are reflective of the short sentiment are summarized in the table below.

Check out ATyr Pharma Basic Forecasting Models to cross-verify your projections. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.

Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.